CytoMed Therapeutics Limited GDTC
0.89 USD -0.02 (-2.31%)
At closeNov 4, 2026, 4:00 PM EST
0.90 +0.01 +1.30%
After hours · Nov 4, 4:00 PM ET
0.8309 Day range 0.8918
0.68 52-week range 3.10
- YTD
- -33.66%
- 1 year
- -55.33%
Analyst view
Price target (mean) 5.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.03 | -0.03 – -0.03 | 0.00 | 0.0% | 156.00K | 0.0% | 1 |
| Next quarter | -0.03 | -0.03 – -0.03 | 0.00 | 0.0% | 156.00K | 0.0% | 1 |
| Current year | -0.15 | -0.15 – -0.15 | -0.28616 | +47.6% | 571.00K | 0.0% | 1 |
| Next year | -0.17 | -0.17 – -0.17 | -0.15 | -13.3% | 520.00K | -8.9% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 10, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Jun 11, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Dec 4, 2023 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Jul 21, 2023 | Benchmark | Initiated | — | Speculative Buy |